(Q42215672)

18 October 2017

title

Primary hypogonadism associated with o,p' DDD (mitotane) therapy (English)

1 reference

18 October 2017

1 reference

Sparagana M

1

1 reference

18 October 2017

publication date

1 January 1987

1 reference

Journal of Toxicology: Clinical Toxicology

18 October 2017

published in

1 reference

18 October 2017

volume

25

1 reference

18 October 2017

issue

6

1 reference

18 October 2017

page(s)

463-472

1 reference

Adrenal cortical carcinoma. Results of treatment with o,p'DDD in 138 patients

18 October 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F15563658708992649

Mitotane Use in Inoperable Adrenal Cortical Carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15563658708992649

Adrenal cortical carcinoma.A study of 32 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15563658708992649

Treatment of Cushing's disease by O,p'DDD. Survey of 62 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15563658708992649

Sustained Remission of Cushing's Disease with Mitotane and Pituitary Irradiation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15563658708992649

Reversible gonadotropin Deficiency in Male Cushing's Dusease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15563658708992649

Complexing of DDT and o,p'DDD with adrenal cytochrome P-450 hydroxylating systems

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15563658708992649

I. General aspects of pesticide use. The chemistry of pesticides

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15563658708992649

10.3109/15563658708992649

21 January 2018

Identifiers

DOI

1 reference

18 October 2017

1 reference